Results
|
41.
|
|
|
42.
|
|
|
43.
|
|
|
44.
|
|
|
45.
|
|
|
46.
|
|
|
47.
|
|
|
48.
|
|
|
49.
|
|
|
50.
|
|
|
51.
|
|
|
52.
|
|
|
53.
|
|
|
54.
|
|
|
55.
|
|
|
56.
|
|
|
57.
|
|
|
58.
|
|
|
59.
|
EGFR mutation status and first-line treatment in patients with stage III/IV non-small cell lung cancer in Germany: an observational study. [electronic resource] by
- Schuette, Wolfgang
- Schirmacher, Peter
- Eberhardt, Wilfried Ernst Erich
- Fischer, Juergen R
- von der Schulenburg, J-Matthias Graf
- Mezger, Joerg
- Schumann, Christian
- Serke, Monika
- Zaun, Silke
- Dietel, Manfred
- Thomas, Michael
Producer: 20160504
In:
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology vol. 24
Availability: No items available.
|
|
60.
|
Using competence network collaboration and decision-analytic modeling to assess the cost-effectiveness of interferon alpha-2b plus ribavirin as initial treatment of chronic hepatitis C in Germany. [electronic resource] by
- Siebert, Uwe
- Sroczynski, Gaby
- Wasem, Jürgen
- Greiner, Wolfgang
- Ravens-Sieberer, Ulrike
- Aidelsburger, Pamela
- Kurth, Bärbel M
- Bullinger, Monika
- von der Schulenburg, J-Matthias Graf
- Wong, John B
- Rossol, Siegbert
Producer: 20091103
In:
The European journal of health economics : HEPAC : health economics in prevention and care vol. 6
Availability: No items available.
|